Phase II study of adjuvant gemcitabine plus docetaxel (GD) for completely resected stage I-IV high grade uterine leiomyosarcoma (HGuLMS)

被引：0
|
作者：
Hensley, M. L. [1 ]
Larkin, J. [1 ]
Ishill, N. [1 ]
Abu-Rustum, N. [1 ]
Sabbatini, P. [1 ]
Konner, J. [1 ]
Tew, W. [1 ]
Spriggs, D. [1 ]
Aghajanian, C. A. [1 ]
机构：
[1] Memor Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5591
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I/II trial of gemcitabine plus treosulfan (GeT) in stage IV uveal melanoma and carcinomas
    Schmittel, Alexander
    Schuster, Ronny
    Bchrakis, Nikolaos
    Siehl, Jan M.
    Foerster, Michael H.
    Thiel, Eckhard
    Keilholz, Ulrich
    ANNALS OF ONCOLOGY, 2004, 15 : 203 - 203
  • [22] ADJUVANT CHEMOTHERAPY IN STAGE I-II UTERINE LEIOMYOSARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY OF 140 PATIENTS.
    Mancari, R.
    Signorelli, M.
    Gadducci, A.
    Lissoni, A.
    Carinelli, S.
    Sesana, S.
    Chiappa, V.
    Tomaselli, T.
    Corso, S.
    Colombo, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [23] ADJUVANT CHEMOTHERAPY DOES NOT PRECLUDE THE NEED FOR PELVIC plus /- PARA-AORTIC LYMPHADENECTOMY IN FIGO STAGE I-IV UTERINE SEROUS CANCER
    Schiemer, R.
    Chattopadhyay, S.
    Nugent, D.
    Broadhead, T.
    Buxton, J.
    Hutson, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [24] THE FEASIBILITY STUDY OF CDDP PLUS DOCETAXEL FOLLOWED BY TS-1 MAINTENANCE AS POST OPERATIVE ADJUVANT CHEMOTHERAPY FOR COMPLETELY RESECTED PATHOLOGICAL STAGE II TO IIIA NSCLC PATIENT
    Sakai, H.
    Suzuki, K.
    Niho, S.
    Ikeda, N.
    Kaburagi, T.
    Koike, T.
    Minato, K.
    Kato, T.
    Okamoto, H.
    Seto, T.
    Hosomi, Y.
    Tsuboi, M.
    Watanabe, K.
    Takeuchi, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 114 - 114
  • [25] Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer
    Shinkyo Yoon
    Changhoon Yoo
    Min-Hee Ryu
    Myoung Joo Kang
    Baek-Yeol Ryoo
    Sook Ryun Park
    Jeong Hwan Yook
    Sung Tae Oh
    Moon-Won Yoo
    Byung Sik Kim
    Yoon-Koo Kang
    Gastric Cancer, 2017, 20 : 182 - 189
  • [26] Phase I/II trial of gemcitabine plus treasulfan (GeT) in stage IV uveal melanoma and carcinomas.
    Schmittel, AH
    Schuster, R
    Bechrakis, N
    Siehl, J
    Foerster, MH
    Thiel, E
    Keilholz, U
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 716S - 716S
  • [27] A Phase II Study of Gemcitabine-Cisplatin plus Necitumumab for Stage IV Sq-NSCLC
    Corral, Jesus
    Ponce, Santiago
    Aerts, Joachim G.
    Tsai, Chun-Ming
    Hao, Desiree
    Cadranel, Jacques
    Beck, J. Thaddeus
    Kim, Sang-We
    Varea, Rocio
    Chao, Grace
    Barriga, Susana
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S424 - S424
  • [28] PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
    Eggermont, Alexander M. M.
    Ascierto, Paolo A.
    Khushalani, Nikhil, I
    Schadendorf, Dirk
    Boland, Genevieve
    Weber, Jeffrey
    Lewis, Karl D.
    Johnson, Daniel
    Rivalland, Gareth
    Khattak, Adnan
    Majem, Margarita
    Gogas, Helen
    Long, Georgina, V
    Currie, Sue L.
    Chien, David
    Tagliaferri, Mary A.
    Carlino, Matteo S.
    Diab, Adi
    FUTURE ONCOLOGY, 2022, 18 (08) : 903 - 913
  • [29] A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
    Azzoli, Christopher G.
    Krug, Lee M.
    Miller, Vincent A.
    Rizvi, Naiyer A.
    Kris, Mark G.
    Dunne, Megan
    Farmer, Amy
    Pizzo, Barbara
    Tyson, Leslie
    Seeger, Teresa
    Coleman, Barbara
    Moore, Erin
    Lastinger, Lauren
    Venkatraman, Ennapadam
    Rudin, Charles M.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (07) : 638 - 644
  • [30] Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
    Scagliotti, GV
    Fossati, R
    Torri, V
    Crinó, L
    Giaccone, G
    Silvano, G
    Martelli, M
    Clerici, M
    Cognetti, F
    Tonato, M
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19): : 1453 - 1461
12345